-
Differential modulation of FXR activity by chlorophacinone and ivermectin analogs.
Toxicology and applied pharmacology 20161215
-
Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.
European journal of clinical pharmacology 20121001
-
Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin.
Journal of cardiothoracic and vascular anesthesia 20120601
-
Intraoperative administration of clevidipine to prevent vasospasm after radial and internal mammary artery grafts during coronary artery bypass grafting.
American journal of therapeutics 20120501
-
Clevidipine : a state-of-the-art antihypertensive drug under the scope.
Expert opinion on pharmacotherapy 20120201
-
Clevidipine for controlled hypotension during spinal surgery in adolescents.
Journal of neurosurgical anesthesiology 20111001
-
Clevidipine for controlled hypotension during spinal surgery in adolescents.
Middle East journal of anaesthesiology 20110601
-
Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis.
Blood pressure. Supplement 20110401
-
Perioperative blood pressure management: walking a tightrope.
Annals of cardiac anaesthesia 20110101
-
Cardiovascular pharmacology: an update.
Anesthesiology clinics 20101201
-
Efficacy of clevidipine in controlling perioperative hypertension in neurosurgical patients: initial single-center experience.
Journal of neurosurgical anesthesiology 20101001
-
Use of clevidipine for intraoperative hypertension caused by an undiagnosed pheochromocytoma: a case report.
AANA journal 20100801
-
Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension.
Pharmacotherapy 20100501
-
Clevidipine: a new intravenous option for the management of acute hypertension.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100301
-
Clevidipine butyrate: a promising new drug for the management of acute hypertension.
Expert opinion on pharmacotherapy 20100201
-
Parenteral nutrition in the critically ill patient.
The New England journal of medicine 20100107
-
Clevidipine for the treatment of severe hypertension in adults.
Clinical therapeutics 20100101
-
Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis.
Congestive heart failure (Greenwich, Conn.) 20100101
-
Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review.
Vascular health and risk management 20100101
-
Preliminary experience with clevidipine in the pediatric population.
Journal of intensive care medicine 20100101
-
Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for treatment of patients with acute severe hypertension answers to the march 2009 journal club questions.
Annals of emergency medicine 20090801
-
A new intravenous calcium channel blocker option to treat acute elevations in blood pressure.
Journal of clinical hypertension (Greenwich, Conn.) 20090701
-
Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
The Annals of pharmacotherapy 20090701
-
New drugs 09, part 2.
Nursing 20090601
-
Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials.
Expert review of cardiovascular therapy 20090501
-
Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension.
Annals of emergency medicine 20090301
-
Clevidipine: a review of its use in the management of acute hypertension.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20090101
-
Clevidipine: a novel ultra-short-acting calcium antagonist.
Cardiology in review 20090101
-
Drug evaluation of clevidipine for acute hypertension.
Expert opinion on pharmacotherapy 20081001
-
The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients.
Anesthesia and analgesia 20081001
-
Novel I.V. drug approved.
Nursing 20081001
-
Clevidipine (Cleviprex) for IV treatment of severe hypertension.
The Medical letter on drugs and therapeutics 20080922
-
FDA approves i.v. calcium-channel blocker.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080915
-
Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial.
Anesthesia and analgesia 20080701
-
Perioperative hypertension management.
Vascular health and risk management 20080601
-
New drugs: Clevidipine butyrate, difluprednate, and tetrabenazine.
Journal of the American Pharmacists Association : JAPhA 20080101
-
Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1.
Anesthesia and analgesia 20071001
-
New therapeutic perspectives with clevidipine: an ultra-short-acting intravenous Ca2+ channel blocker.
Expert opinion on investigational drugs 20070901
-
New drugs for hypertension: what do they offer?
Current hypertension reports 20061001
-
Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.
Drug metabolism and disposition: the biological fate of chemicals 20060501
-
Current diagnosis and management of hypertensive emergency.
Seminars in dialysis 20060101
-
Failure to demonstrate myocardial protective effects of the ultra short-acting calcium antagonist clevidipine in a closed-chest reperfusion porcine model.
Journal of cardiovascular pharmacology 20041001
-
Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control.
Cardiovascular drug reviews 20040101
-
Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery.
European journal of anaesthesiology 20030901
-
Cardiac sympathetic nerve stimulation triggers coronary t-PA release.
Arteriosclerosis, thrombosis, and vascular biology 20030601
-
Calcium antagonist clevidipine reduces myocardial reperfusion injury by a mechanism related to bradykinin and nitric oxide.
Journal of cardiovascular pharmacology 20021001
-
Clevidipine (the Medicines Company).
Current opinion in investigational drugs (London, England : 2000) 20021001
-
Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II.
Journal of cardiovascular pharmacology 20020901
-
Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part I.
Journal of cardiovascular pharmacology 20020801
-
Clevidipine in adult cardiac surgical patients: a dose-finding study.
Anesthesiology 20020501
-
Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats.
Clinical and experimental hypertension (New York, N.Y. : 1993) 20020501
-
Clevidipine.
Drugs in R&D 20020101
-
Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium.
Cardiovascular research 20010701
-
Fast enantioselective separation of clevidipine and a dihydropyridine substituted acid by SFC on Chiralpak AD.
Fresenius' journal of analytical chemistry 20010101
-
Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients.
Chirality 20010101
